TNXP icon

Tonix Pharmaceuticals
TNXP

Overview Fund Activity

7 hedge funds and large institutions have $2.14M invested in Tonix Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BC
1
Broadfin Capital
New York
$1.75M
2
DCM
2
DAFNA Capital Management
California
$164K
3
Morgan Stanley
3
Morgan Stanley
New York
$128K
4
RHBC
4
R.H. Bluestein & Co
Michigan
$91K
5
First Manhattan
5
First Manhattan
New York
$9K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
BC
1
Broadfin Capital
New York
$1.75M 478,000 +478,000 New
DCM
2
DAFNA Capital Management
California
$164K 45,000 +45,000 New
Morgan Stanley
3
Morgan Stanley
New York
$128K 35,000 +35,000 New
RHBC
4
R.H. Bluestein & Co
Michigan
$91K 25,000 +25,000 New
First Manhattan
5
First Manhattan
New York
$9K 2,500 +2,500 New
TRCT
6
Tower Research Capital (TRC)
New York
$3K 911 +911 New
Barclays
7
Barclays
United Kingdom
$2K 600 +600 New